Fujifilm to invest $40 Million to Establish a New State-of-the-Art Viral Vector and Advanced Therapy Process Development and Manufacturing Facility
Fujifilm notes the new facility is scheduled to begin process development operations in fall 2021.
Fujifilm selected caresyntax as their supplier because the team has a demonstrated history in developing data-driven integration that provides the total visibility to achieve increased workflow efficiency, patient safety, and surgical performance.
This new option uses tomosynthesis guidance to calculate 3D coordinates of a suspicious lesion in the breast, in addition to the traditional stereotactic method; allowing radiologists to accurately complete biopsy of suspicious areas to conduct a pathological examination and inform the diagnosis and care plan.
Fujifilm To Announce Multiple Image Processing And Software Advancements For Its ASPIRE Cristalle Digital Mammography System
11/15/18: The company will premiere several new image processing and software advancements during RSNA 2018, for its digital mammography system, ASPIRE Cristalle. The full suite of advancements designed to enhance clinical imaging while lowering dose includes S-View, Iterative Super Resolution (ISR), Tomosynthesis Biopsy, Tomosynthesis Spot, Breast Density Measurement and Comfort Comp*. These features will be available for demonstration at booth #2545 at McCormick Place in Chicago during the annual meeting of the Radiological Society of North America.
Fuji Film Announces Entry into the U.S. Computed Tomography Marketing with Unveiling of FCT Embrace at ASTRO 2018
10/22/18: Powered by Analogic, the FCT Embrace is the world’s first 85cm wide bore computed tomography (CT) imaging unitwith 64 or 128 slice configurations.
7/18/18: “With expertise in diagnostic imaging and healthcare IT, Fujifilm is well recognized as a valuable partner to radiology departments across the United States,” said Robert Fabrizio, director of strategic marketing, digital radiography and women’s health, FUJIFILM Medical Systems U.S.A., Inc. “With the introduction of Fujifilm’s pediatric imaging portfolio, designed to optimize image quality at a low dose, Fujifilm is committed to facilitate best practices in pediatric imaging that improve patient safety and comfort.”
7/11/18: “Fujifilm DR solutions are engineered to provide gentle dose without sacrificing image quality and even assist in infection controls with an exclusive antibacterial coating – making them ideal for imaging pediatric patients,” said Robert Fabrizio, Director of Strategic Marketing, Digital Radiography and Women’s Health, FUJIFILM Medical Systems U.S.A., Inc. “We are honored to participate in the Vizient Preferred Pediatric Program. We look forward to working with Vizient members to provide imaging solutions that help enhance safety in pediatric imaging.”
Three Healthcare Systems Select Fujifilm’s Digital Radiography Solutions To Enhance Diagnostic Imaging and Patient Care
FUJIFILM Medical Systems U.S.A., Inc., today announced that three healthcare systems across the United States have chosen Fujifilm’s DR solutions to enhance imaging capabilities and patient outcomes. “These facilities’ recent selections of Fujifilm digital imaging by new and...
12Page 1 of 2